• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Visual outcomes of small-aperture IOL implant in post-laser refractive eyes

Video
Conferences|AAO

Robert Ang, MD, discusses highlights of his AAO 2020 presentation on a study analyzing the vIsual outcomes of a small-aperture IOL implantation in patients with a history of post-laser refractive surgery.


Robert Ang, MD, director, Refractive Surgery Department, Asian Eye Institute (Philippines), discusses highlights of his AAO 2020 presentation on a study titled, "Visual outcomes of small-aperture IOL implantation in post-laser refractive eyes."

See more AAO coverage

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Deb Ristvedt, DO's CIME 2024 Talk Highlights Innovations in Treating Glaucoma via the Trabecular Meshwork
Dr. Inder Paul Singh's Insights: Improving Glaucoma Outcomes with Early Intervention and Reduced Medication
CIME 2024: Kelsey Roelofs, MD, details collaborative strategies for the management of thyroid eye disease
CIME 2024: Diagnostic tips and treatments for managing Demodex blepharitis
CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion
Related Content
Adaptilens closes Series A financing round of $17.5 million to help drive development of the company's Accommodating Intraocular Lens

Adaptilens closes Series A financing round of $17.5 million to help drive development of the company's Accommodating Intraocular Lens

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
BVI Medical launches PODEYE, a hydrophobic monofocal IOL, in Japan

BVI Medical launches PODEYE, a hydrophobic monofocal IOL, in Japan

Article
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Podcast
Roivant announces positive NEPTUNE study results for brepocitinib in non-infectious uveitis

Roivant announces positive NEPTUNE study results for brepocitinib in non-infectious uveitis

Article
SpyGlass Pharma unveils 1-year data of drug delivery platform implanted during routine cataract surgery in patients diagnosed with glaucoma

SpyGlass Pharma unveils 1-year data of drug delivery platform implanted during routine cataract surgery in patients diagnosed with glaucoma

Article
© 2024 MJH Life Sciences

All rights reserved.